ArticleGut microbes2020
Reuterin disrupts
Abstract read
In one paragraph
Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Trial
- Reuterin alleviates Enterohemorrhagic Escherichia coli O157:H7-induced infectious diarrhea in mice through modulation of the gut microbiota.World journal of microbiology & biotechnology · 2026Article
- Animal gut microbes and microbiomes in the 21st century and beyond.Science China. Life sciences · 2026Review
- Ecological and dietary strategies to constrain Clostridioides difficile.Cell host & microbe · 2026Review
- Lactic Acid Bacteria-Derived Antimicrobial and Anti-Biofilm Strategies: Mechanisms, Functional Molecules, and Emerging Biomaterial Applications.International journal of molecular sciences · 2026Review
- Carbadox, a veterinary growth promoter exhibits anticlostridial activity through induction of oxidative stress in Clostridioides difficile.Gut pathogens · 2026Article
- Research Progress on the Role ofBiology · 2026Review
- Human milk and infant formula influence lactobacilli metabolism in a species-specific manner.NPJ science of food · 2026Article
- Lactic Acid Bacteria-Derived Secondary Metabolites: Emerging Natural Alternatives for Food Preservation.Probiotics and antimicrobial proteins · 2026Review
- Genome-wide association analysis reveals specialization to hosts and niches in multiple species of the Lactobacillaceae.The ISME journal · 2026Article
- gNODE: gLV model-informed neural ordinary differential equations for modeling microbial community dynamics.Frontiers in cellular and infection microbiology · 2026Article
- Factors influencing gut microbial colonization: A host-microbe-environment interaction perspective.Current research in food science · 2026Review
- Bacterial vesicles-initiatedTheranostics · 2026Article
- Unravelling three-way interactions betweenJournal of medical microbiology · 2025Review
- Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy.Pharmacology & therapeutics · 2025Review
- Covalent Organic Frameworks-Delivered Reuterin Drives Trained Immunity in Tumor-Associated Macrophages to Enhance Melanoma Immunotherapy via Glycerophospholipid Metabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Article
- Hydrogel-Transformable Probiotic Powder for Targeted Eradication of Helicobacter pylori with Enhanced Gastric Mucosal Repair and Microbiota Preservation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Bioengineered Probiotics for Clostridioides difficile Infection: An Overview of the Challenges and Potential for This New Treatment Approach.Probiotics and antimicrobial proteins · 2025Review
- The Impact ofMicroorganisms · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Melinda A EngevikDepartment of Pathology & Immunology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0002-9742-9932
Heather A DanhofDepartment of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0002-6347-0021
Ritu ShresthaDepartment of Biology, Texas A&M University , College Station, TX, USA.
Alexandra L Chang-GrahamDepartment of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0002-3403-6787
Joseph M HyserDepartment of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, TX, USA.
Anthony M HaagDepartment of Pathology & Immunology, Baylor College of Medicine , Houston, TX, USA.
Mahmoud A MohammadDepartment of Pediatrics, Children's Nutrition Research Center, Baylor College of Medicine , Houston, TX, USA.
Robert A BrittonDepartment of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0001-8983-9539
James VersalovicDepartment of Pathology & Immunology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0002-5765-4385
Joseph A SorgDepartment of Biology, Texas A&M University , College Station, TX, USA.ORCID 0000-0001-7822-2656
Jennifer K SpinlerDepartment of Pathology & Immunology, Baylor College of Medicine , Houston, TX, USA.ORCID 0000-0002-7830-7665
Funding
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3MProject 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVIDGE, TOR C. · 2020 to 2025
$12.0MProteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8MResearch Training in Pediatrics GastroenterolgyT32DK007664 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI DOUGLAS G BURRIN · 1991 to 2026
$8.4MDecoding Antibiotic-induced Susceptibility to Clostridium difficile InfectionU01AI124290 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, GAREY, KEVIN W · 2016 to 2020
$7.9MTraining Supplement in Enteric Virus Exploitation of Calcium SignalingR01DK115507 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Joseph M. Hyser · 2018 to 2026
$5.0MMechanisms of Clostridium difficile spore germinationR01AI116895 · NIAID · TEXAS A&M UNIVERSITY · PI SORG, JOE · 2015 to 2024
$3.9MDiet driven evolution of epidemic ribotypes of Clostridium difficileR01AI123278 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A · 2018 to 2022
$2.0MIdentifying the role of serotonin receptor 4 and trefoil factor 3 in intestinal wound repairK01DK123195 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ENGEVIK, MELINDA ANNE · 2020 to 2024
$612kMetabolic adaptation drives pathogenicity of C. difficile epidemic strain RT078F32AI136404 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI DANHOF, HEATHER A. · 2019 to 2021
$191kNIAID NIH HHS F32 AI136404NIAID NIH HHS P01 AI152999NIAID NIH HHS R01 AI116895NIAID NIH HHS R01 AI123278NIAID NIH HHS U01 AI124290NIDDK NIH HHS K01 DK123195NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK123704NIDDK NIH HHS R01 DK115507NIDDK NIH HHS T32 DK007664
Abstract
Antibiotic resistance is one of the world's greatest public health challenges and adjunct probiotic therapies are strategies that could lessen this burden.
Indexed as
Anti-Bacterial AgentsClostridioides difficileDrug SynergismEpithelial CellsGlyceraldehydeHumansLimosilactobacillus reuteriOrganoidsOxidative StressProbioticsPropaneReactive Oxygen SpeciesSpores, Bacterial3-hydroxypropionaldehydeAnti-Bacterial AgentsGlyceraldehydePropaneReactive Oxygen SpeciesClostridioides difficileenteroidsLactobacillus reuterimetabolismorganoidsoxidative stressprobioticsreactive oxygen speciesReuterin
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.